• Sox17 regulates germ layer specification by promoting endoderm differentiation while simultaneously repressing mesectoderm fates.
INTRODUCTION
During embryogenesis, the pluripotent zygote progressively gives rise to specialized cell types expressing distinct sets of genes that, in turn, define the cell's identity and encode proteins necessary for its function. Lineage specific gene expression is controlled by the genomic integration of signaling pathways and transcription factors (TFs) on DNA cis-regulatory modules (CRMs), such as enhancers, that control transcription (Heinz et al., 2015; Stevens et al., 2017) .
An important goal of developmental biology is to elucidate how signaling effectors and TFs interact on distinct sets of CRMs within the chromatin landscape to form gene regulatory networks (GRNs) that activate lineage-specific transcriptional programs whilst repressing expression of alternative fates. This will provide a deeper understanding of how transcriptional cell states are established, dysregulated in disease, and how GRNs might be manipulated for therapeutic purposes.
We have addressed this in the context of endoderm germ layer specification: one of the earliest cell fate decisions in vertebrate development that provides a relatively simple model to elucidate how GRNs control lineage-specific transcriptional programs (Charney et al., 2017b) . In embryos and pluripotent stem cells (PSCs), Nodal/Smad2 and Wnt/ß-catenin (Ctnnb1; hereafter Bcat) signaling cooperate to initiate the mesendoderm program and subsequent development of definitive endoderm (DE) progenitors, which gives rise to the epithelia of the digestive and respiratory systems (Sumi et al., 2008; Zorn and Wells, 2009 ). Downstream of Nodal and Wnt, a core set of endoderm TFs: Sox17, Gata4-6, Eomes, Foxa1/2 and Mix family of homeodomain TFs execute the endoderm GRN (Arnold et al., 2008; Charney et al., 2017b; Engert et al., 2013; Sinner et al., 2006) . In Xenopus where endoderm specification is well studied, the Nodal and Wnt pathways interact at several levels. First, maternal (m) Wnt/Bcat, active on the dorsal side of the blastula, is required for high levels of nodal expression at the onset of zygotic transcription (Hyde and Old, 2000) . Then Nodal and mWnt cooperate to promote the expression of endoderm TFs Sox17, Foxa2 and many dorsal mesendoderm organizer genes (Xanthos et al., 2002) . A few hours later zygotic (z) wnt8 (a Nodal target) is expressed on the ventral side of the gastrula where, together with Nodal signaling, it promotes ventral and posterior mesendoderm identities (Charney et al., 2017b; Stevens et al., 2017) . In mammals early Wnt/Bcat similarly activates expression of Nodal and core endoderm TFs, with prolonged Wnt promoting posterior hindgut fate (Engert et al., 2013; Zorn and Wells, 2009) . Functional interactions between the core endoderm TFs and the Wnt pathway are critical to: 1) segregate the transient mesendoderm into endoderm and mesoderm, 2) pattern the nascent endoderm into spatially distinct subtypes and 3) execute the downstream differentiation program to give rise to endoderm-derived lineages. But mechanistically, how the Wnt signaling machinery interacts with core endoderm TFs to execute this differentiation cascade is unresolved. The transcriptional targets of the endoderm TFs are largely unknown, and it is unclear exactly how Wnt regulates distinct spatiotemporal transcription programs in the embryo. Indeed, how the canonical Wnt pathway elicits context-specific transcription in its multitude of different biological roles from development, homeostasis and cancer is still poorly understood. According to the dogma of canonical Wnt signaling, Wnt-activated Fzd-Lrp5/6 receptor complexes stimulate the stabilization and translocation of Bcat to the nucleus. There, it interacts with one of four Tcf HMGbox TFs (Tcf7, Tcf7L1, Tcf7L2 and Lef1) at Wnt-responsive CRMs (Cadigan and Waterman, 2012; Schuijers et al., 2014) to assemble a "Wnt-enhanceosome" complex with the scaffold proteins Bcl9, Pygopus and Ldb (Gammons and Bienz, 2018) . In the absence of Bcat, Tcfs are coupled with co-repressor proteins Tle/Groucho and Hdac to inhibit transcription. Bcat displaces Tle and recruits a co-activator complex including histone acetyltransferases Ep300 or Cbp to stimulate transcription (Cadigan and Waterman, 2012) . How distinct context-specific Wnt target genes are selected is unclear since Tcfs have nearly identical DNA-binding specificities (Badis et al., 2009; Ramakrishnan and Cadigan, 2017) and for the most part they are ubuiqitously expressed. An emerging idea is that the Wnt-enhanceosome also interacts with other lineagespecific TFs (Gammons and Bienz, 2018; Trompouki et al., 2011 ); yet, how these impact genomic specificity in vivo is largely untested and the idea of Tcf-independent Wnt-mediated transcription remains controversial.
Here we investigated the possibility that Sox17 functionally interacts with Wnt/Bcat to regulate transcription in the Xenoups endoderm GRN. In all vertebrate embryos, Sox17 is specifically expressed in the gastrula endoderm where it is required for early gut development (Clements et al., 2003; Hudson et al., 1997; Kanai-Azuma et al., 2002) . SOX17 is also a commonly used marker of definitive endoderm fate in differentiating PSC cultures (Wang et al., 2011) . Despite the critical role for Sox17 in endoderm development, only few of its direct transcriptional target genes have been identified (e.g.: hnf1b, foxa1 and dhh) (Ahmed et al., 2004; Sinner et al., 2004; Yagi et al., 2008) . In Xenopus, ectopic Sox17 is sufficient to initiate endoderm development in pluripotent blastula animal cap cells (Clements et al., 2003; Hudson et al., 1997) , and co-injection of stabilized Bcat can enhance this activity (Sinner et al., 2004) . Sox17 can physically interact with Bcat in vitro and suppress the transcriptional activity of generic Tcf/Bcat-multimer driven reporter constructs (pTOPflash) in tissue culture experiments (Sinner et al., 2007; Zorn et al., 1999) . However, the biological relevance of these interactions and whether Sox17 and Bcat functionally interact on chromatin to regulate the endoderm GRN remains unknown.
Here, we defined the genomic targets of Sox17 in the Xenopus gastrula. In addition to promoting expression of endoderm genes, Sox17 also represses ectoderm and mesoderm gene transcription, and acts in a negative feedback loop to restrain Nodal signaling. We demonstrate that functional interaction with canonical Wnt signaling is a key feature of the Sox17-regulated GRN. Over a third of all Bcat and Sox17 genomic binding in the gastrula occur at the same loci.
In some instances, Sox17 suppressed Bcat-Tcf mediated transcription, while in other cases, Sox17 and Bcat synergistically activated other enhancers apparently independently of Tcfs, indicating a novel mode of regulation These results provide new insight into the GRN controlling endoderm development and have implications for how Sox proteins and Bcat might interact across diverse biological contexts from development to cancer.
Results

Sox17 regulates a genomic program controlling germ layer segregation and endoderm development
To identify the transcriptional program regulated by Sox17, we performed RNA-sequencing (RNAseq) on control and Sox17-depleted Xenopus tropicalis embryos at multiple time points during blastula and gastrula stages (NF9-12) when the endoderm germ layer is being specified. In Xenopus tropicalis there are three redundant genes; sox17a, sox17b.1 and sox17b.2 (collectively sox17) with indistinguishable activities and identical expression in presumptive vegetal endoderm cells of gastrula embryos ( Fig. 1A and Fig. S1A ) (D'Souza et al., 2003; Hellsten et al., 2010) .
Microinjection of a combination of antisense morpholino oligos (sox17aMO and sox17bMO)
targeting all 3 paralogs resulted in a robust knockdown of Sox17 protein as confirmed by immunostaining (Fig. 1C,B and Fig. S1 ). The Sox17-MO phenotype was consistent with previous reports where about half of the embryos arrested in gastrulation with (Clements et al., 2003; Sinner et al., 2006) and remaining embryos phenocopied mouse mutants with defective gut development (Kanai-Azuma et al., 2002) . Injection of mRNA encoding mouse Sox17 rescued both the anatomical and gene expression phenotypes confirming the MOs efficacy and specificity (Fig. S1C, D) .
Differential expression analysis of control-MO and Sox17-MO embryos identified 1023
Sox17-regulated genes (> 2-fold change, FDR< 5%) ( Fig. 1D and Table S1 ). Gene Ontology (GO) enrichment was consistent with the Sox17-regulated transcriptome being involved in "endoderm formation", "epithelial differentiation" and "digestive track morphogenesis" (Fig. S1E) . In total 493 genes were downregulated in Sox17-depleted embryos and 530 genes were upregulated. The time course data revealed that >75% of the differentially expressed genes were Sox17-dependent during the mid-late gastrula (NF10.5-12), consistent with a role in maintaining the endoderm fate after initial induction by Nodal signaling in the blastula (NF9) ( Fig.1D and Fig. S1A ). Sox17regulated genes comprised of 73 TFs, including known targets foxa2 and hnf1b (Sinner et al 2004; Sinner et al 2006) , and paracrine signaling components (Table S1 ) such as the Hedgehog pathway (dhh, hhip, gli1); a key epithelial signal in gut organogenesis. This confirms that Sox17 sits atop of the regulatory hierarchy regulating endoderm differentiation.
We next investigated how Sox17-regulated genes were spatially expressed; to do so, we leveraged previously published RNA-seq data set of different tissues dissected from gastrula embryos (Blitz et al., 2017) . As predicted, a majority of Sox17-dependent genes were enriched in the vegetal endoderm and dorsal mesendoderm (organizer) ( The observation that over 10% of Sox17-regulated genes are enriched in the organizer mesendoderm while Sox17 is present throughout the endoderm, suggested that in addition to Nodal, Sox17 functionally interacts with the dorso-ventral patterning Wnt and/or Bmp pathways to control spatial expression. Intriguingly, we found that Sox17 regulates the expression of several Wnt/Bcat pathway components and targets including: dkk1, dkk2, fzd5, nodal3.1, pygo1, sia1, ror1, rsop2 and wnt11 (Fig. 1D, F and Table S1 ). This suggests that Sox17 regulates both endoderm specification and patterning while suppressing mesectoderm fate and that to do so, Sox17 participates in feedback loops with the Wnt and Nodal pathways.
Sox17 ChIP-Seq reveals direct endodermal targets that are Nodal and Wnt pathway components
To identify direct Sox17-targets we generated and validated anti-Sox17 antibodies ( Fig. S2 ) and
performed ChIP-seq analysis (biological replicates) of early gastrula (NF10.5) embryos, identifying 8436 statistically significant Sox17-bound CRMs (Irreproducible Discovery Rate (p<0.05). These were associated with 4801 genes ( Fig. 2A ). 88% of the Sox17-binding regions were in introns or intergenic regions more than 1kb away from the transcription start site, consistent with the presence of distal CRMs (Fig. S3A ). A comparison to publically available p300
ChIP-seq data at the same stage (Hontelez et al., 2015) showed that most of the Sox17-bound genomic loci were also bound by Ep300, ( A comparison to published ChIP-Seq data from human PSC-induced definitive endoderm (Tsankov et al., 2015) revealed that 20% of the Xenopus Sox17-bound genes were also SOX17bound in human DE ( Fig S3) . GO analysis of the conserved Sox17-bound genes show an enrichment for 'Tgfb receptor activity' and 'Bcat binding' (Fig S3) reinforcing the notion that Sox17 interactions with components of Nodal and Wnt pathways is a conserved feature of the endoderm GRN.
Intersecting the RNA-seq and ChIP-seq data identified 315 genes, corresponding to ~30% of the Sox17-regulated transcriptome, that showed Sox17 chromatin binding (609 peaks) and are therefore likely to be direct transcriptional targets ( Fig. 2A ). These putative direct targets were significantly enriched (44%, 139/315 of transcripts) for expression in the endoderm or dorsal mesendoderm ( Fig. 2D ). Of the Sox17-bound and regulated genes, 197 genes (383 peaks) were positively regulated by Sox17 (down in Sox17MOs) consistent with Sox17 directly activating their transcription including slc5a8, hnf1b, foxa1 and dhh ( Fig. 2E ), which were previously suggested to be direct Sox17-targets. 118 putative direct targets were negatively regulated by Sox17 (up in Sox17MOs) including ectodermal genes (lhx5, foxi2 and tfap2a), endoderm-enriched Nodal pathway genes (nodal1, gdf3, gdf6 and mix1) and Wnt-regulated organizer genes (dkk and fst), suggesting direct transcriptional repression ( Fig. 2E ). Motif analysis ( Fig S3B) revealed that ~45% of peaks associated with Sox17-activated genes were also enriched for LIM-homeodomain TFs, whereas Sox17-repressed genes were enriched for Tbx or Pou TFs, suggesting a likely regulatory logic where Sox17 has distinct modes of transcriptional activation or repression depending on context-specific cofactor TFs.
These analyses provide new insight into the endoderm GRN and reveal previously unappreciated roles for Sox17 in germ layer segregation and endoderm patterning involving functional interactions with the Nodal and Wnt pathways. These findings, together with our previous work demonstrating that Sox17-Bcat can physically interact in vitro (Sinner et al., 2007; Zorn et al., 1999) prompted us to investigate the biological relevance of any such Sox17/Bcat interaction further.
The b-catenin-regulated gastrula transcriptome is enriched for endodermal genes
To test the hypothesis that Sox17 and Bcat functionally interact in vivo, we set out to identify Bcatregulated genes and compare these to the Sox17-regulated transcriptome. Injection of a well- Table S2 ).
Remarkably the Bcat-dependent genes encoded 251 TFs, (~15% of all the TFs in the genome), reinforcing the notion that Wnt/Bcat is involved in multiple transcriptional cascades in the early embryo.
Intersecting the Bcat-MO RNA-seq data with previously published Bcat ChIP-seq data As expected, many of the positively regulated Bcat targets had enriched expression in the dorsal mesoderm ( Fig. 3D) including most known organizer genes such as; cer1, chrd, dkk1, frzb, fst and gsc. In contrast ~30% of Bcat-bound genes with increased expression in the early Bcat-MO embryos (NF7-9) were enriched for ectoderm specific transcripts, consistent with the expansion of ectoderm and loss of neural tissue in ventralized embryos ( Fig. 3D ). We also identify many direct Bcat targets that are likely to be regulated by zygotic Wnt8, (Kjolby and Harland, 2017; Nakamura et al., 2016) including sp5, axin2, cdx1/2, fzd10, msgrn1 and eight hox genes, all of which were downregulated in Bcat-MOs (Fig. 3A , E). A number of zygotic Wnt-targets with enriched expression in the ventral mesoderm were components of BMP pathway including; bambi, bmp7, id2, msx1, smad7, szl, ventx1 , and ventx3 (collectively known as the BMPsynexpression group) (von Bubnoff et al., 2005) ; most of these genes are known to be directly activated by both Bmp4/Smad1 and zWnt8/Bcat (Itasaki and Hoppler, 2010; Stevens et al., 2017) .
Consistent with this , these were upregulated in Bcat-depleted embryos, likely due to the increase in BMP/zWnt8 signaling in ventralized embryos.
Most importantly almost 200 Bcat-bound and regulated genes had endoderm enriched expression ( Fig. 3D and Table S2 ). De novo motif analysis of showed that Bcat bound peaks were significantly more enriched for Sox than canonical Tcf motifs ( Fig. 3C; Fig. S5 ?), consistent with the hypothesis that Sox17 and Bcat co-regulate endoderm gene transcription in vivo.
Contrary to the prevailing view that Bcat promotes endoderm fate primarily by activating Nodal ligand expression, these results also suggest a direct input by Wnt/Bcat into the endoderm GRN.
Sox17 and b-catenin co-occupy CRMs to regulate the endoderm GRN
Comparison of the Sox17-MO and Bcat-MO RNA-seq datasets identified 415 transcripts that were regulated by both Sox17 and Bcat, representing ~40% of the Sox17-regulated and ~15% of the Bcat-regulated transcriptome (Fig. 3A ). Intersection with their ChIP-seq datasets identified 3956 genomic loci bound by both Sox17 and Bcat, suggesting a direct co-regulation of at least a subset of these enhancers( Fig. 4A ). Peak density analysis using published ChIP-seq data (Charney et al., 2017a; Hontelez et al., 2015; Paraiso et al., 2019) indicated that the cobound loci had epigenetic signatures of active enhancers (Fig. 4B ). Homer motif analysis showed that these were much more enriched for Sox DNA-binding sites than Tcf sites ( Fig S5A) .
In total, 84 genes (191 Peaks) were bound and regulated by both Sox17 and Bcat, representing ~30% of direct Sox17 targets and ~10% of direct Bcat targets (Fig. 4A ). This is likely to be an underestimation of the number of direct coregulated genes, as these genes had to pass a stringent thresholding comprising of four independent statistical tests to be included in this list.
A detailed motif analysis of the 191 cobound and coregulated peaks using the comprehensive CIS-BP database (Weirauch et al., 2014) revealed that 78% (149/191) were predicted to contain both Sox17 and Tcf DNA-binding motifs, often > 5 sites in each peak (e.g., dkk1, lhx5 and osr1) ( Fig. 4D ). In contrast ~21% (40/191) of the peaks had Sox motifs but no obvious Tcf consensus sites (e.g., six1), suggesting that Bcat might be recruited to these loci independent of Tcfs. Only 1/191 peaks had Tcf but no Sox motifs. In most cases individual genes were associated with multiple cobound peaks suggesting that combinatorial binding and integration of several CRMs is crucial to control transcription.
Since the ChIP-seq experiments were performed on whole embryos, it was possible that Sox17 and Bcat chromatin binding might occur in different cell populations. To test whether Sox17 and Bcat bound the same enhancers in the same cells we performed ChIP-reChIP experiments.
First anti-Bcat ChIP was performed on 500 gastrulae. DNA eluted from the first ChIP was then re-precipitated with either anti-Sox17 or a negative control IgG antibody. All 4 loci tested by ChIP-reChIP QPCR (six1, dkk1, lhx5 and gli1) showed enrichment compared to IgG demonstrating that these genomic loci (~150 bp in length) were simultaneously bound by Sox17 and Bcat in endodermal cells. In contrast a negative control locus gtse1 which is bound by Bcat but not Sox17 was not recovered in the ChIP-reChIP experiment (Fig. 4F ).
The 84 cobound and coregulated genes fell into 4 regulatory categories ( Fig. 4E) ; 32/84 were activated by both Sox17 and Bcat (e.g., six1, slc5a8 and osr1), 27/84 were activated by Bcat but repressed by Sox17 (e.g., dkk1, lhx5 and nodal1), 19/84 were positively regulated by Sox17 and negatively regulated by Bcat (up in the Bcat MO) and finally 6/84 appeared to be negatively regulated by both Sox17 and Bcat. The observation that Bcat positively regulated most of these genes (59/84, 70%) was consistent with its known role in transcriptional activation. Sox17 positively regulated 60% of targets and repressed 40% of targets, suggesting context-dependent activity. For further analysis we focused on the two major regulatory groups; genes/enhancers activated by both Sox17-Bcat and activated by Bcat but repressed by Sox17.
Sox17 and Bcat epistasis suggests a functional interaction between these two factors
It was possible that the overlap in Sox17-and Bcat-regulated genes was due entirely by Sox17 and Wnt interacting in a regulatory feedback loop. Bcat might be required for the robust expression of nodal and sox17 and Sox17 protein, in turn, regulates the expression of Wntpathway components. While this is likely to partially account for Bcat/Sox interactions, we directy tested the functional necessity for both Sox17 and Bcat in epistasis experiments, asking whether injection of Sox17 RNA could rescue candidate coregulated genes in Bcat depleted embryos and vice versa. We found that co-injection of mSox17 mRNA could not rescue the normal expression patterns of six1, osr1, lhx5 or dkk1 in Bcat-MO embryos, but it did rescue foxa1 expression ( Fig.   5 ). This indicates that a reduction of Sox17 downstream of Bcat depletion cannot account for the disrupted expression of six1, osr1, lhx5 or dkk1. Simillarly co-injection of stabilized Bcat mRNA rescued the normal expression of foxa1 but not six1, osr1, lhx5 or dkk1 in Sox17-morphants indicating that the impact on gene expression was not just due to disruption of Wnt signaling downstream of Sox17 depletion (Fig. 5 ). These data support the notion that Sox17 and Bcat functionally interact to regulate transcription of these key genes by directly engaging their enhancers.
Sox17 and Bcat synergistically regulate transcription of endodermal enhancers.
To examine how Sox17 and Bcat directly regulate endodermal transcription, we selected two exemplar cobound enhancers: a) a proximal six1 enhancer located at -1kb from the transcription start site (TSS) and b) a dkk1 enhancer located -1.6kb from its TSS (Fig. 6B ). six1 and and dkk1 are both expressed in the dorsal mesendoderm of the organizer (Fig. 5 ), but have opposite regulation. Sox17-Bcat promotes six1, whilst Sox17 represses Bcat activation of dkk1.
The -1kb six1 enhancer is evolutionarily conserved from Xenopus to human containing three Sox-binding sites but no predicted Tcf motifs (Fig. 6B ). In mouse, this enhancer can drive transgenic expression in the embryonic gut tube (although the TFs that modulate it were previously unknown) (Sato et al., 2012) . Analysis of published ChIP-seq data indicate that, like in Xenopus, the human SIX1 CRM is also bound by SOX17 in human PSC-derived endoderm ( Fig.   S6B ) (Tsankov et al., 2015) .
Mammalian Dkk1 is known to be a direct Bcat-Tcf target in human tissue culture (Niida et al., 2004) but the CRMs that regulate its expression in the gastrula are have not been characterized. Unlike six1, the -1.6kb dkk1 enhancer harbors both Tcf and Sox DNA-binding sites ( Fig. 6B , file S1)
We cloned these CRMs into luciferase (luc) reporter constructs and tested whether they require Sox17 and Bcat for their enhancer activity in Xenopus embryos. Targeted microinjection into different cells of 32-cell-stage Xenopus embryos ( Fig 6A) showed that the -1six1:luc or -1.6dkk1:luc reporters recapitulated the endogenous spatial expression. They were both active in the dorsal-anterior endoderm, but not the ventral endoderm or ectoderm, indicating that they are bona fide enhancers (Fig.6C, E To test whether Sox17 and Bcat were sufficient to regulate the -1six1 and -1.6dkk1 enhancers, we assayed their activity in ectoderm (animal cap) tissue which does not express endogenous Sox17 and has low Wnt/Bcat activity. Injection of mSox17 but not ca-Bcat mRNA was sufficient to stimulate the -1kbsix1:luc reporter in the ectoderm, but co-injection of Bcat along with mSox17 mRNA was required to robustly and synergistically activate the reporter. On the other hand, Bcat but not mSox17 mRNA was able to activate the dkk1:luc in ectodermal cells, and co-injection of mSox17 suppressed the ability of Bcat to stimulate the reporter, consistent with the endogenous dkk1 regulation. The ability of Sox17 to activate the -1six1:luc or suppress Bcat-induced -1.6dkk1:luc activation required the DNA-binding function of Sox17. A M76A point mutation in mSox17, known to disrupt the DNA-binding HMG domain (Sinner et al., 2007) abolished Sox17's activity in both cases (Fig. 6C) . The six1 enhancer is predicted to have only Sox sites with no evidence of Tcf binding sites. To formally test whether or not it is regulated by Tcfs, we injected a Tcf3-VP16 fusion construct which constitutively activates Tcf-target gene transcription (Darken and Wilson, 2001) . As predicted, this had little to no impact on the six1:luc reporter. From these data, we conclude that six1 expression is regulated by a mechanism wherein Sox17 and Bcat synergize to promote activation, likely in a Tcf-independent manner. Additionally, we mutated all three predicted Sox17 motifs in the six1 enhancer, and this abolished all reporter activity, further confirming that Sox17 is necessary to regulate this enhancer ( Fig S6C) .
In contrast, the dkk1 enhancer is predicted to have both Sox17 and Tcf DNA-binding sites.
To formally test whether or not this enhancer is regulated by Tcfs, we mutated two of the predicted Tcf binding sites which abolished reporter activity, consistent with the idea of Tcf/Bcat mediated transcription ( Fig 6F) . Co-injection of mSox17 significantly downregulated Bcat-dependent activation at this enhancer. Consistent with this, mutating two predicted Sox17 binding sites, as well as coinjection with Sox17MO led to increased reporter activity ( Fig 6F) . 
DISCUSSION
Overview of findings
Sox17 is a key regulator of vertebrate endoderm development and morphogenesis, yet surprisingly the transcriptional program that it regulates has been poorly characterized until now.
Here we defined the Sox17-regulated GRN in Xenopus gastrulae, which includes many conserved genes also defined as genomic targets of SOX17 in PSC-derived human DE. We show that in addition to acting atop a transcriptional hierarchy promoting endoderm differentiation, Sox17 has previously unappreciated roles in endoderm patterning amd germ layer segregation.
We demonstrate that functional interaction with canonical Wnt signaling pathway is a major Maternal Sox3 localized in the blastula ectoderm directly binds the nodal5/6 enhancers to repress transcription, whereas vegetally localized maternal Sox7 promotes nodal5/6 expression in the vegetal cells (Zhang and Klymkowsky, 2007) . This suggests a potential handoff model where different Sox TFs bind the same enhancers in different cells to activate or repress transcription in a context-dependent manner.
Motif analysis revealed that Sox17 bound loci were also enriched for Tbx and Gata motifs indicating that in addition to regulating each others expression, the core endoderm TFs act together in combinatorial manner, perhaps to establish endodermal super enhancers crucial for downstream lineage specification (Paraiso et al., 2019) . Interestingly, enhancers that were negatively regulated by Sox17 were enriched for Tbx and Oct motifs whereas enhancers activated by Sox17 were enriched for homeodomain motifs. This suggests that Sox17 interactions with distinct lineage-specific TFs could elicit a context-specific transcriptional response. In the future, it will be important to identify and integrate the genomic targets of all the core endoderm-specifying TFs and examine how combinatorial enhancer binding is integrated into a unified endodermal GRN. 
DNA Binding Specificity of SOX TFs
Sox-Bcat-Tcf Interactions
Many SOX proteins, including Sox17, can bind to recombinant Bcat and Tcfs in vitro and modulate Wnt/Bcat-simulated transcription of synthetic reporters assays with multimerized Tcf-sites (pTOPFlash) (Sinner et al., 2007; Zorn et al., 1999) . While a number of models have been Another possibility is that Sox17 might also impact Wnt transcriptional responses by recruiting cofactors that post-translationally modify Bcat-complexes or alter the local chromatin landscape. Post-translational modifications of both nuclear Bcat or Tcfs on different residues have been shown to impact DNA-binding, stability and their ability to interact with components of the basal transcriptional machinery (Gao et al., 2014; Masuda and Ishitani, 2017; Ramakrishnan and Cadigan, 2017; Valenta et al., 2012) . For example, acetylation of Bcat at lysine 49 by Cbp (K49Ac) promotes lineage-specific transcriptional activation, whereas tri-methylation of the same residue by Ezh2 blocks activation of alternate lineage genes (Hoffmeyer et al., 2017) . It is unclear how these co-factors are targeted to Bcat at specific genomic loci, and we postulate that Sox17 could play a role in recruiting transcriptional coactivators/repressors to a subset of lineage-specific endoderm enhancers.
Broader Implications
Although a growing number of other Bcat-binding TFs have been reported, (Gammons and Bienz, 2018; Notani et al., 2010; Trompouki et al., 2011) , how these impact genomic specificity of Wntresponsive transcription has previously not been well characterized and the idea of Tcfindependent transcription remains controversial (Doumpas et al., 2019; Schuijers et al., 2014) .
Our data suggests that Sox17, Bcat and Tcfs interact on enhancers to regulated Wnt-responsive transcription in the gastrula endoderm and in some cases Sox17 and Bcat appear to act independent of Tcfs. Considering that there are over 20 Sox TFs encoded in the vertebrate genome with most cell types expressing at least one, it is possible that SOX factors are widespread and previously unappreciated accessory effectors of Bcat that finetune Wnt-regulated transcription in many biological contexts.
Methods
Xenopus embryo manipulations:
Xenopus laevis and Xenopus tropicalis were purchased from Nasco or the National Xenopus Resource Center and housed according to established CCHMC IACUC protocols.
Plasmids used to produce linear templates for mRNA synthesis using the mMessage mMachine In-situ hybridization: In situ hybridization of Xenopus tropicalis embryos was performed as described (Sive et al 2000) with the following minor modifications. Embryos were fixed overnight (12-16 hours) at 4°C in MEMFA (0.1 M MOPS, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde), washed in MEMFA buffer without the formaldehyde 2x10 minutes, dehydrated directly into 100% ethanol, washed 4-6 times in 100% ethanol, and stored at -20°C for at least 24 hours. On day 1, after 7 minute re-hydration steps through a graded ethanol series (95%, 75%, 60%, 40% on ice, 25% in PBS on ice, PBS), embryos were bisected through the dorsal-ventral axis in PBS+0.01%
Tween-20 on 2% agarose coated dishes using a fine double-edge razor blade (Electron Microscopy Services 72003-01). Proteinase K (ThermoFisher AM2548) treatment was performed at 1ug/mL for 10 minutes on bisected gastrula embryos. TEA/Acetic Annhydride steps were skipped on day1. The RNAse A step was 0.25ug/mL for 5 minutes on day 2; and finally the anti-DIG-alkaline phosphatase antibody (Sigma 11093274910) was used at a 1:6,000 dilution in MAB buffer (maleic acid buffer, 100 mM Maleic acid, 150 mM NaCl, pH7.5) + 20% heat-inactivated lamb serum (Gibco 16070096) + 2% blocking reagent (Sigma 11096176001) on day2/3. Antisense DIG labeled in situ probes were generated using linearized plasmid full-length cDNA templates with the 10X DIG RNA labeling mix (Sigma 11277073910) according to manufacturer's instructions. Details on plasmids used for probe synthesis are listed in supplementary table S7.
Luciferase Assays: Putative enhancers of interest were cloned into the pGL4.23 luc2/miniP vector. (Promega E8411). 5pg of pRL-TK-renilla luciferase vector (Promega E2241) was coinjected with 50pg of the pGL4.23 luc2/miniP:enhancer of interest:firefly luciferase constructs.
Injected X.laevis embryos were cultured overnight at 15 0 C until stage NF10.5. Pools of 5 embryos were collected in a single microfuge tube and either snap frozen on dry ice, stored indefinitely at -80 0 C until lysis, or lysed directly in 100uL of 100mM TRIS-Cl pH7.5. Lysates were centrifuged for 10 minutes at ~13,000 x g and then 25uL of the clear supernatant lysate was used separately in Firefly (Biotium #30085-1) and Renilla (Biotium 30082-1) luciferase assays according to the manufacturer's instructions. To determine relative luciferase activity, Firefly levels were divided by Renilla levels for each sample; each black dot in the graphs in Fig.6 and   supplemental fig.S6 represents the relative luciferase activity of a pool of 5 injected embryos.
Total amounts of mRNAs and MOs injected into X.laevis embryos in luciferase assays were as follows: 5pg ca-Bcat, 25pg mSox17, 25pg mSox17 M76A, 10pg Tcf3-VP16, 20ng Xl sox17a+b1/2 MO(10ngeach), 10ng Xl bcat MO.
RNA isolation: Total RNA was extracted from 10 embryos in three independent biological replicates with the Nucleo-spin RNA kit (Machery-Nagel). RNA-seq: RNA-seq libraries were generated using Smart-seq2 cDNA synthesis followed by tagmentation, quality-tested using an Agilent Bioanalyzer 2100, quantified using KAPA qPCR and sequenced using Illumina sequencers at the UC Irvine Genomics High Throughput Facility.
Chromatin Immunoprecipitation
ChIP-qPCR experiments were carried out largely as described in (Hontelez et al., 2015) with some modifications. Briefly, NF 10.5 Xenopus tropicalis embryos were fixed in 1% formaldehyde in 0.1x MBS at room temperature for 30 minutes. Sonication was carried out in a Diagenode Bioruptor Pico instrument for 30 cycles of 30 seconds ON, 30 seconds OFF. The following antibodies were then added to the chromatin extract: 10 µl anti-Sox17-Cterminal antibody(affinitiy purified by Bethyl labs, FigS2) or 20 µl anti-b-catenin (Life Technologies, 712700) and the lysate with the antibody was incubated overnight with end over end rotation at 4°C. After washes and elution, DNA was then purified using a MinElute PCR Purification kit and QIAQuick purification columns and eluted in 20µl TE. ChIP-qPCR: For qPCR, the ChIP DNA was diluted 25 fold in nuclease-free dH2O. The input sample was diluted equally and dilution series of 0.1%, 0.01% and 0.001% was prepared to assess DNA recovery after ChIP. qPCR was carried out using a QuantStudio 3 Real-Time PCR machine. Relative fold change was plotted using GraphPad Prism v8. ChIP-reChIP: Before the first ChIP, the antibodies were crosslinked to beads. The antibody solution (20 ul anti-b-catenin (Life Technologies, 712700)) was prepared in 5%BSA/PBS and then added to the bead slurry at a 1:1 ratio. The solution was mixed and end-over-end rotated for 2 hours at 4°C. The antibody bound beads were washed with PBS and then with 0.2M sodium borate pH 9. Crosslinking solution was prepared by adding 1ml of 13mg/ml dimethyl pimelimidate to 1ml of 0.2M sodium borate pH9. This solution was mixed well and 10 volumes were added to the antibody bound beads. Crosslinking took place by end-over-end rotation for 30 min at room temperature. The reaction was then quenched by washing the beads with 0.2M ethanolamine pH 8 for an hour at room temperature. Excess unlinked antibody was removed by washed with 1M glycine pH 3 for 10 minutes at room temperature. ChIP assay was then carried out as described above. At the end of the first ChIP, DNA was eluted with elution buffer supplemented with 10mM DTT. The eluate was then diluted in 10 volumes of wash buffer (50mM Tris-HCl pH 8.0, 100mM NaCl, 2mM EDTA, 1% NP-40) supplemeted with 1x Protease Inhibitor Cocktail and 1mM DTT.
The 2 nd ChIP was then carried out as a normal ChIP as described above. ChIP-Sequencing:
Large scale ChIP was carried out as previously described (Charney et al., 2017a) and ChIP-seq libraries were generated using Nextflex ChIP-seq kit (Bioo Scientific), analyzed using an Agilent Bioanalyzer 2100, quantified using KAPA qPCR and sequenced using Illumina instruments at the UC Irvine Genomics High Throughput Facility.
Bioinformatic Analysis:
RNA-Seq: Xenopus genome and annotations of version 9.0 were obtained from Xenbase.org (Karimi et al., 2018) RNA-Seq Analysis: Raw RNA-Seq reads were generated in duplicates for control and mutant conditions across timepoints ranging from NF stages 7 to 12. Raw reads were quality checked using FastQC and adapters/low quality reads were removed with Trimmomatic To assess the spatial expression of transcripts we examined the TPM expression values in dissected stage 10.5 embryos from published data in GEO GSE81458 (Blitz et al., 2017) .
Normalized expression was then used to obtain genes with enriched expression in a specific tissue if it was 1.5x of mean expression across dissections. statistical significance of enriched expression pattern in groups of genes was determined by chi-square test p<0.05 performed in R package MASS.
ChIP-Seq Analysis: Raw reads were assessed for quality-control by FastQC and read trimming was performed wherever necessary with Trimmomatic. Reads were aligned to Xenopus tropicalis genome version 9.0 using bowtie2 v2. 3.4.7 (Langmead and Salzberg, 2012 Landt et al., 2012) . For IDR analysis aligned reads with MAPQ > 30 were retained using samtools and converted to bam files. Bam files were then converted to tagAlign format and each replicate was shuffled to generate two pseudoreplicates using unix shuf and awk. Each pseudoreplicate was then converted to a tagAlign file. MACS2 was used to call peaks for each pseudoreplicate using a low confidence threshold of p < 0.01 against the merged input tagAlign file. These peaks were then used as input for IDR at a threshold of 0.01 to generate highly reproducible peaks. Peaks were annotated using HOMER v4.1.0 and default parameters using the function annotatePeaks.pl (Heinz et al., 2010) .
To visualize the data, aligned bam files generated as above were converted to bigwig format using Bedtools v2. 27.1(Quinlan and Hall, 2010) and visualized on IGV v2.4.1.3 (Thorvaldsdottir et al., 2013) .
Motif analysis:
De-novo motif analysis was performed with HOMER using the function findMotifsGenome.pl. For a comprehensive Sox and Tcf motif analysis, we divided our datasets into 3 groups: a) Peaks bound and regulated by Sox17 only, b) Peaks bound and regulated by Bcat Only and c) Peaks that were cobound and coregulated by Sox17 and Bcat. DNA sequences of 150 bp centered on the peaks summits were extracted and motif analysis was carried out as follows: 1. To find which peaks have instances of Sox17 and Tcf motifs, HOMER function annotatePeaks.pl was used with the parameters: -size 150 -m motif sox17.motif tcf7.motif lef1.motif tcf3.motif tcf7l2.motif. 2., To perform an exhaustive motif scan PWMs identified from direct binding experiments for Sox17, Tcf7, Tcf7l1 and Lef1 were downloaded from CIS-BP (Weirauch et al., 2014) . The 150 bp DNA sequences were scanned for the presence of these PWMs and a threshold of > 70% was used to identify putative DNA binding sites. Results were merged to generate BED files using bedtools merge function denoting the chromosome coordinates of each putative binding site with each 150bp sequence.. Bedtools intersect function was then used to extract coordinates into 'Sox only' 'Tcf only' and 'Sox and Tcf overlapping' categories.
ChIP-Seq Heatmaps: From the Sox17 and Bcat peaks called by MACS2, Bedtools intersect function was used to stratify the peaks into 'Sox bound only', 'Bcat bound only' and 'Sox and Bcat overlapping peaks'. For each category of peaks, the peak summit was extracted from the TF summit file generated by MACS2 and 2000 bp were added to both sides of the summit using awk. Bedtools computematrix was used to generate per genome regions. The generated matrix was then used with bedtools plotHeatmap to generate heatmaps and signal density plots.
Gene Ontology: Gene ontology enrichment analysis was performed using the Gene Ontology Consortium Online Resource (http://geneontology.org).
Analysis of public datasets:
The following datasets were downloaded from GEO: GSE72657 (Nakamura et al., 2016) , GSE85273 (Charney et al., 2017a) , GSE56000 (Gupta et al., 2014) and GSE67974 (Hontelez et al., 2015) . Wherever necessary, raw data was downloaded from GEO and aligned to Xenopus genome version 9.0, and post-alignment processing to generate bigwig files and heatmaps was carried out as describd above.
Data and software availability:
Raw and Processed RNA-seq and ChIP-seq data generated by this study are available at NCBI Gene Expression Omnibus GSE#pending 
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